HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account
All About CARVYKTI for Multiple Myeloma
Posted: May 27, 2022
All About CARVYKTI for Multiple Myeloma image

All About CARVYKTI

What is CARVYKTI? CARVYKTI is a CAR-T cell therapy that was recently approved. Find out below all about how CARVYKTI works.

7.19    All About CARVYKTI

 

We’d like to thank our faculty who donated their time in creating these videos, including:

  • Peter Voorhees, MD
  • Adam Cohen, MD

Want more?

We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!

 

The author Cynthia Chmielewski

about the author
Cynthia Chmielewski

Cynthia (Cindy) Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University. You can follow her on Twitter @myelomateacher

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Abbvie
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube